Advancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally.
View Top Employees from NeuroSense Therapeutics| Website | http://www.neurosense-tx.com/ |
| Employees | 30 (19 on RocketReach) |
| Founded | 2017 |
| Address | 1 Broadway, Cambridge, Massachusetts 02142, US |
| Phone | +972 9-953-1142 |
| Technologies |
JavaScript,
HTML,
PHP
+21 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Neuroscience |
Looking for a particular NeuroSense Therapeutics employee's phone or email?
NeuroSense Therapeutics Questions
Ferenc Tracik is the Chief Medical Officer of NeuroSense Therapeutics.
19 people are employed at NeuroSense Therapeutics.
NeuroSense Therapeutics is based in Cambridge, Massachusetts.
Top NeuroSense Therapeutics Employees
-
31
-
1
Related Companies
